Oncology Information Center

News

Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

Adjuvant Pembrolizumab Beneficial in Stage III Melanoma

Pembrolizumab linked to significantly longer recurrence-free survival at 15-month follow-up

Advanced Ovarian Cancer Survival Rates Longer After Primary Cytoreductive Surgery Compared With Neoadjuvant Chemotherapy

Researchers found a superior survival rate in patients who received primary cytoreductive surgery as opposed to neoadjuvant chemotherapy for stage IIIC and IV high-grade serous ovarian carcinoma.

FDA Approves Multi-Cancer Treatment Drug

The FDA has approved Rubraca, a poly (ADP-ribose) polymerase inhibitor, to treat patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Pap Tests May Help Diagnose Endometrial, Ovarian Cancers

Genetic mutations assays using PapSEEK may facilitate the detection of certain cancers using fluids from Pap tests.

Vigil Immunotherapy and PARP 7 Treatments for Patients with Ovarian Cancer

Vigil immunotherapy is possible for women with recurrent ovarian cancer and PARP 7 may impact ovarian cancer survival, according to two studies presented in New Orleans.

Prostate-specific antigen screening helps prostate cancer detection

Prostate cancer was diagnosed more frequently in men who underwent single prostate-specific antigen screening than in those who did not, but mortality was unaffected.

NCCN's anticancer drug recommendations beyond FDA approval based on weak evidence

Does weak evidence drive the NCCN recommendations of FDA-approved drugs?

CLINICAL FEATURES

Case Study: Chest pain and shortness of breath in a patient with colorectal cancer

Case Study: Chest pain and shortness of breath in a patient with colorectal cancer

A 64-year-old woman who was recently diagnosed with colorectal cancer is brought to the emergency department with substernal chest pain and shortness of breath.

Breast cancer screening: a review of current mammography guidelines

Breast cancer screening: a review of current mammography guidelines

Consensus regarding mammography screening varies, and conflicting guidelines from medical organizations can cause confusion for patients and providers.

Sign Up for Free e-newsletters